Know Cancer

or
forgot password

Micro RNA's Associated With Lymph Node Metastasis in Endometrial Cancer


N/A
N/A
N/A
Not Enrolling
Female
Endometrial Cancer

Thank you

Trial Information

Micro RNA's Associated With Lymph Node Metastasis in Endometrial Cancer


OBJECTIVES:

- To identify microRNA expression patterns associated with lymph node metastasis in
samples from patients with endometrial cancer.

OUTLINE: Banked tumor tissue specimens are analyzed for microRNA expression profiling by
microarray analysis and reverse transcriptase-PCR assays.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Histologically confirmed endometrioid endometrial cancer

- Stage IA, IB, IC, or IIIC disease

- Any grade

- Enrolled and evaluated on GOG-0210 Molecular Staging Study of Endometrial Cancer

- Consented to allow their specimens and clinical data to be collected and stored
for future research

- Underwent complete surgical staging, including the following:

- Hysterectomy

- Bilateral oophorectomy

- Washings as well as pelvic lymphadenectomy (sampling of four left and four right
pelvic lymph nodes)

- Para-aortic lymphadenectomy (sampling of one left and one right para-aortic
lymph node)

- Sufficient high-quality frozen primary tumor for testing with ≥ 75% tumor cellularity
and ≤ 10% necrosis

PATIENT CHARACTERISTICS:

- Not specified

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

Type of Study:

Observational

Study Design:

N/A

Outcome Measure:

Association between microRNA expression and lymph node metastasis

Safety Issue:

No

Principal Investigator

David S. Miller, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Simmons Cancer Center

Authority:

Unspecified

Study ID:

CDR0000672415

NCT ID:

NCT01119573

Start Date:

May 2010

Completion Date:

Related Keywords:

  • Endometrial Cancer
  • stage I endometrial carcinoma
  • stage III endometrial carcinoma
  • Endometrial Neoplasms
  • Sarcoma, Endometrial Stromal
  • Adenoma

Name

Location